Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity

Metabolism: Clinical and Experimental

Volumn 48, Issue 10, 1999, Pages 1332-1335

  Tsigos, Constantine ^a   Kyrou, Ioannis ^b   Chala, Eftychia ^b   Tsapogas, Panayotis ^b   Stavridis, John C ^b   Raptis, Sotirios A ^b   Katsilambros, Nikolaos ^b  

^a Hellenic National Diabetes Center   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMEN; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MORPHOMETRICS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032743517     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90277-9     Document Type: Article

References (25)

1. Akira S, Hirano T, Taga T, et al: Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 4:2860-2867, 1990
2. Grunfeld C, Feingold KR: The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3:143-158, 1991
3. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
4. Hotamisligil GS, Spiegelman BM: TNFα: A key component of obesity-diabetes link. Diabetes 43:1271-1278, 1994
5. Hotamisligil GS, Arner P, Caro JF, et al: Increased adipose expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
6. Saghizadeh M, Ong JM, Garvey WT, et al: The expression of TNFα by human muscle: Relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
7. Kern PA, Saghizadeh M, Ong JM, et al: The expression of tumor necrosis factor in adipose tissue: Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
8. Hotamisligil GS, Murray DL, Choy LN, et al: Tumor necrosis factor a inhibits signalling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994
9. Liu LS, Spelleken M, Rohrig K, et al: Tumor necrosis factor-a acutely inhibits insulin signalling in human adipocytes. Diabetes 47:515-522, 1998
10. Hotamisligil GS, Peraldi P, Budavari A, et al: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a- and obesity-induced insulin resistance. Science 271:665-668, 1996
11. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoids. J Clin Endocrinol Metab 83:847-850, 1998
12. Besedovsky HO, Del Ray A: Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 17:64-102, 1996
13. Papanicolaou DA, Petrides J, Tsigos C, et al: Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271 :E601-E605, 1996
14. Tsigos C, Papanicolaou DA, Defensor R, et al: Dose-effects of recombinant human interleukin-6 on anterior pituitary hormone secretion and thermogenesis. Neuroendocrinology 66:54-62, 1997
15. Tsigos C, Papanicolaou DA, Kyrou I, et al: Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82:4167-4170, 1997
16. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151-153, 1992
17. Aderka D, Engelmann H, Maor Y, et al: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329, 1992
18. Katsuki A, Sumida Y, Murashima S, et al: Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862, 1998
19. Winkler G, Salamon F, Salamon D, et al: Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in type II (non insulin-dependent) diabetes and in obesity. Diabetologia 41:860-861, 1998
20. Dandona P, Weinstock R, Thusu K, et al: Tumor necrosis factor-α in sera of obese patients: Fall with weight loss. J Clin Endocrinol Metab 83:2907-2910, 1998
21. Hsueh WA, Law RE: Cardiovascular risk continuum: Implications of insulin resistance and diabetes. Am J Med 105:4S-14S, 1998 (suppl)
22. Pickup JC, Mattock MB, Chusney GD, et al: NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1997
23. Kirchgessner TG, Uysal KT, Wiesbrock SM, et al: Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782, 1997
24. Mantzoros CS, Moschos S, Avramopoulos I, et al: Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 82:3408-3413, 1997
25. Vgontzas AN, Papanicolaou DA, Bixler Eo, et al: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316, 1997